Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Cerebral Small Vessel Diseases

glucose, (beta-d)-isomer has been researched along with Cerebral Small Vessel Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hirose, M; Ishida, N; Saito, M; Sanbe, A; Sato, S; Taira, E; Tezuka, Y	1

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Cerebral Small Vessel Diseases

Article	Year
Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease. Pharmacology research & perspectives, 2021, Volume: 9, Issue:5 Topics: Animals; Carotid Artery, Common; Cerebral Small Vessel Diseases; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Glucosides; Hippocampus; Inflammation; Mice; Morris Water Maze Test; Neurons; Phlorhizin; Pyrazoles; Sodium-Glucose Transporter 1	2021

Article

Year

Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease.

Pharmacology research & perspectives, 2021, Volume: 9, Issue:5

Topics: Animals; Carotid Artery, Common; Cerebral Small Vessel Diseases; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Glucosides; Hippocampus; Inflammation; Mice; Morris Water Maze Test; Neurons; Phlorhizin; Pyrazoles; Sodium-Glucose Transporter 1

2021